Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)

SHE:002020 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	3,925	4,086	3,920	3,717	3,401	3,214
Other Revenue	72.73	72.73	78.89	62.81	65.06	44.25
Revenue	3,998	4,159	3,999	3,780	3,467	3,258
Revenue Growth (YoY)	-6.63%	3.99%	5.79%	9.04%	6.40%	-10.66%
Cost of Revenue	2,051	2,098	1,988	1,774	1,547	1,277
Gross Profit	1,947	2,061	2,011	2,006	1,920	1,981
Selling, General & Admin	757.17	916.47	994.61	984.94	970.72	1,178
Research & Development	388.32	383.34	400.79	367.04	334.14	257.91
Other Operating Expenses	115.3	33.52	30.09	36.19	26.57	28.02
Operating Expenses	1,268	1,346	1,432	1,392	1,342	1,462
Operating Income	679.01	714.56	579.08	613.8	577.8	519.31
Interest Expense	-5.52	-7.74	-7.31	-6.01	-4.97	-6
Interest & Investment Income	77.98	80.2	66.71	85.05	96.29	79.73
Currency Exchange Gain (Loss)	2.93	2.93	3.43	14.43	-3.84	-9.77
Other Non Operating Income (Expenses)	-7.91	-3.4	-0.97	-3.21	-7.19	-9.77
EBT Excluding Unusual Items	746.49	786.54	640.94	704.06	658.09	573.49
Gain (Loss) on Sale of Investments	-43.19	-42.37	24.44	10.15	7.23	131.49
Gain (Loss) on Sale of Assets	1.93	2.59	6.86	0.61	-0.48	-0.04
Asset Writedown	-8.4	-0.07	-0.01	-0.07	-8.42	-0.51
Other Unusual Items	135.6	97.3	35.81	35.56	43.12	54.54
Pretax Income	832.43	843.98	708.04	750.32	699.54	758.98
Income Tax Expense	112.45	124.85	84.62	82.49	81.57	105.65
Earnings From Continuing Operations	719.98	719.13	623.42	667.82	617.96	653.33
Minority Interest in Earnings	-7.42	-7.16	-4.52	-5.57	-5.42	-0.26
Net Income	712.56	711.96	618.9	662.25	612.54	653.07
Net Income to Common	712.56	711.96	618.9	662.25	612.54	653.07
Net Income Growth	-1.21%	15.04%	-6.55%	8.12%	-6.21%	25.50%
Shares Outstanding (Basic)	831	858	860	860	817	796
Shares Outstanding (Diluted)	831	858	860	860	817	796
Shares Change (YoY)	-3.25%	-0.21%	-0.06%	5.31%	2.55%	-6.90%
EPS (Basic)	0.86	0.83	0.72	0.77	0.75	0.82
EPS (Diluted)	0.86	0.83	0.72	0.77	0.75	0.82
EPS Growth	2.11%	15.28%	-6.49%	2.67%	-8.54%	34.80%
Free Cash Flow	501.59	475.52	273.32	340.2	-33.37	179.21
Free Cash Flow Per Share	0.60	0.55	0.32	0.40	-0.04	0.23
Dividend Per Share	0.350	0.350	0.300	0.300	0.300	0.292
Dividend Growth	16.67%	16.67%	-	-	2.84%	-
Gross Margin	48.71%	49.56%	50.30%	53.06%	55.39%	60.80%
Operating Margin	16.98%	17.18%	14.48%	16.24%	16.67%	15.94%
Profit Margin	17.82%	17.12%	15.48%	17.52%	17.67%	20.04%
Free Cash Flow Margin	12.55%	11.43%	6.83%	9.00%	-0.96%	5.50%
EBITDA	1,006	989.48	784.87	766.56	713.89	642.51
EBITDA Margin	25.16%	23.79%	19.63%	20.28%	20.59%	19.72%
D&A For EBITDA	326.78	274.93	205.79	152.76	136.09	123.2
EBIT	679.01	714.56	579.08	613.8	577.8	519.31
EBIT Margin	16.98%	17.18%	14.48%	16.24%	16.67%	15.94%
Effective Tax Rate	13.51%	14.79%	11.95%	10.99%	11.66%	13.92%
Revenue as Reported	3,998	4,159	3,999	3,780	3,467	3,258
Advertising Expenses	-	-	-	-	5.13	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.